Haleon Plc Form 6-K Summary
Business Context and Reporting Period
This Form 6-K filing by Haleon Plc, dated June 13, 2025, reports a specific corporate action regarding the company's share buyback programme. Haleon is a global leader in consumer health with a portfolio spanning Oral Health, Vitamins, Minerals and Supplements (VMS), Pain Relief, Respiratory Health, Digestive Health, and Therapeutic Skin Health. The filing details transactions executed on June 12, 2025.
Key Financial Metrics
The filing does not provide revenue, profit, cash flow, margin, debt, or liquidity metrics. It focuses exclusively on share repurchase activity:
- Shares Purchased: 971,129 ordinary shares
- Purchase Date: June 12, 2025
- Highest Price Paid: 400.40 pence per share
- Lowest Price Paid: 396.80 pence per share
- Volume Weighted Average Price: 398.75 pence per share
- Post-Transaction Share Capital: 8,997,529,998 ordinary shares
- Treasury Shares Held: 4,080,205
- Voting Shares Outstanding: 8,993,449,793
Material Changes
The primary material change is the reduction of the company's share count due to the cancellation of 971,129 shares purchased under the Buyback Programme announced on March 28, 2025. Consequently, the number of ordinary shares with voting rights has decreased to 8,993,449,793.
Guidance, Outlook, and Risks
The filing contains no financial guidance, outlook, management commentary on operational performance, or discussion of risks and contingencies. It strictly serves as a regulatory disclosure of the share transaction in compliance with the Market Abuse Regulation (Article 5(1)(b)).
Investor Verification Checklist
- Verify the total number of shares repurchased to date under the March 28, 2025 Buyback Programme.
- Confirm the remaining authorization limit for the share buyback programme.
- Review the full breakdown of individual trades available via the provided London Stock Exchange link.
- Check the company's website for updated capital structure details.